PROBUPHINE

knight therapeutics inc.🇨🇦 Health Canada

Approval Id: 80bc7fd6a89edf2e
Drug Approval Canada Name: PROBUPHINE
Product Name: PROBUPHINE
Status: Cancelled Post Market
Status Date: 2023-06-30
Original Market Date: 2018-11-22
Din: 02474921
Drug Class: Human
Dosage Form: Implant
Route Of Administration: Subcutaneous
Schedule: Narcotic (CDSA I)
Ahfs: 28:08.12
Atc Original: N07BC01 BUPRENORPHINE
Atc Name: n 07 bc 01
Aig Number: 0126788005
Company Name: knight therapeutics inc.
Company Address: 1055, 3400 De Maisonneuve Blvd W, Montreal, Quebec, Canada, H3Z 3B8

BUPRENORPHINE HYDROCHLORIDE

80 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

80bc7fd6a89edf2e

Type

Standard